Skip to main content
NIH funding notice RFA-AI-24-011

Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)

Closed on July 30, 2024.

Posted
March 21, 2024
Close date
July 30, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,517,096 in first-year total cost, median $3,258,548.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 KSW-A (J1)]2

Most frequent institutions

  1. WEILL MEDICAL COLL OF CORNELL UNIV1
  2. WISTAR INSTITUTE1
Competing awards under RFA-AI-24-011 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Individualized HIV Curative Combination Strategy against Persistent HIV on ART1UM1AI191272-01MONTANER, LUIS JSILICIANO, ROBERT FWEISSMAN, DREWWISTAR INSTITUTE, PA$3,568,644ZAI1
2025INSPIRE: Innovative Strategies for Personalized Immunotherapies and Reservoir Eradication1UM1AI191237-01CASKEY, MARINAJONES, R. BRADNUSSENZWEIG, MICHEL CWEILL MEDICAL COLL OF CORNELL UNIV, NY$2,948,452ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-24-011: Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed) | ScienceDex | ConductScience